North America Gastrointestinal Drugs Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, and Others); Route of Administration (Oral, and Parenteral); Application (Inflammatory Ulcerative Colitis, Crohn's Disease, Irritable Bowel Syndrome, Gastroenteritis, Celiac Disease, and Others); and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country

No. of Pages: 133    |    Report Code: TIPRE00016278    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Gastrointestinal Drugs Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Gastrointestinal Drugs Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Gastrointestinal Drugs Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing prevelance of gastrointestinal diosrders creates demnad for gastrointestinal drugs
5.2 Market Opportunities
  • 5.2.1 Strategic Initiatives by Companies are likely to create ample opportunities in the coming years
5.3 Future Trends
  • 5.3.1 Increasing research investment for novel drug development and artificial intelligence-based techniques are the key trand in coming years
5.4 Impact of Drivers and Restraints

6. North America Gastrointestinal Drugs Market Regional Analysis

6.1 North America Gastrointestinal Drugs Market Overview
6.2 North America Gastrointestinal Drugs Market Revenue 2017-2027 (US$ Million)
6.3 North America Gastrointestinal Drugs Market Forecast Analysis

7. North America Gastrointestinal Drugs Market Analysis – by Drug Class

7.1 Acid Neutralizers
  • 7.1.1 Overview
  • 7.1.2 Acid Neutralizers: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Antidiarrheal and Laxatives
  • 7.2.1 Overview
  • 7.2.2 Antidiarrheal and Laxatives: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Anti-Inflammatory Drugs
  • 7.3.1 Overview
  • 7.3.2 Anti-Inflammatory Drugs: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Antiemetic and Antinauseants
  • 7.4.1 Overview
  • 7.4.2 Antiemetic and Antinauseants: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Biologics
  • 7.5.1 Overview
  • 7.5.2 Biologics: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Gastrointestinal Drugs Market Analysis – by Route of Administration

8.1 Oral
  • 8.1.1 Overview
  • 8.1.2 Oral: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Parenteral
  • 8.2.1 Overview
  • 8.2.2 Parenteral: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9. North America Gastrointestinal Drugs Market Analysis – by Application

9.1 Inflammatory Ulcerative Colitis
  • 9.1.1 Overview
  • 9.1.2 Parenteral: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Crohn's Disease
  • 9.2.1 Overview
  • 9.2.2 Parenteral: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Irritable Bowel Syndrome
  • 9.3.1 Overview
  • 9.3.2 Parenteral: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Gastroenteritis
  • 9.4.1 Overview
  • 9.4.2 Parenteral: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Celiac Disease
  • 9.5.1 Overview
  • 9.5.2 Parenteral: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

10. North America Gastrointestinal Drugs Market – North America Analysis

10.1 North America
  • 10.1.1 North America Gastrointestinal Drugs Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 North America Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 US: North America Gastrointestinal Drugs Market Breakdown, by Drug Class
    • 10.1.1.1.2 US: North America Gastrointestinal Drugs Market Breakdown, by Route of Administration
    • 10.1.1.1.3 US: North America Gastrointestinal Drugs Market Breakdown, by Application
  • 10.1.1.2 Canada: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Canada: North America Gastrointestinal Drugs Market Breakdown, by Drug Class
    • 10.1.1.2.2 Canada: North America Gastrointestinal Drugs Market Breakdown, by Route of Administration
    • 10.1.1.2.3 Canada: North America Gastrointestinal Drugs Market Breakdown, by Application
  • 10.1.1.3 Mexico : North America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Gastrointestinal Drugs Market Breakdown, by Drug Class
    • 10.1.1.3.2 Mexico : North America Gastrointestinal Drugs Market Breakdown, by Route of Administration
    • 10.1.1.3.3 Mexico : North America Gastrointestinal Drugs Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Gastrointestinal Drugs Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Johnson and Johnson Services, Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bausch Health
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 AbbVie Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 LEXICON PHARMACEUTICALS, INC
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Takeda Pharmaceutical Company Limited
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Gastrointestinal Drugs Market

The List of Companies - North America Gastrointestinal Drugs Market

  1. Johnson and Johnson Services, Inc.
  2. Bausch Health
  3. AbbVie Inc
  4. LEXICON PHARMACEUTICALS, INC
  5. Takeda Pharmaceutical Company Limited
north-america-gastrointestinal-drugs-market